SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-002728
Filing Date
2017-01-18
Accepted
2017-01-18 17:03:59
Documents
1
Period of Report
2017-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v456994_3.html 3  
1 OWNERSHIP DOCUMENT v456994_3.xml 3 5556
  Complete submission text file 0001144204-17-002728.txt   7244
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Issuer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address
Sliman Joseph A. (Reporting) CIK: 0001694213 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12584 | Film No.: 17534027